Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2014-2018
Title: Tatiana Genrihovna Tolstikova: Innovator in Medical Chemistry
Introduction
Tatiana Genrihovna Tolstikova is a prominent inventor based in Novosibirsk, Russia. She has made significant contributions to the field of medical chemistry, particularly in the development of analgesic agents and treatments for Parkinson's disease. With a total of 2 patents, her work showcases her dedication to advancing medical science.
Latest Patents
Tatiana's latest patents include innovative compounds that have the potential to revolutionize pain management and neurological treatment. One of her notable inventions is the use of 2H-chromene derivatives as analgesic agents. This invention relates to the application of a compound of general formula 1 or its spatial isomers as an analgesic drug. The compounds exhibit high activity and low toxicity, making them suitable for medical use. Another significant patent is for an agent designed to treat Parkinson's disease. This invention involves the use of 3-methyl-6-(1-methylethenyl)cyclohex-3-ene-1,2-diol, along with its isomers and derivatives. This compound is highly active, low toxic, and can be synthesized from the readily available natural compound α-pinene.
Career Highlights
Throughout her career, Tatiana has worked with various companies, including Leofors and Tomsk Pharmaceutical Factory. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to the development of effective medical solutions.
Collaborations
Tatiana has collaborated with notable colleagues, including Alla Viktorovna Pavlova and Konstantin Petrovich Volcho. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.
Conclusion
Tatiana Genrihovna Tolstikova stands out as a dedicated inventor in the field of medical chemistry. Her innovative patents and collaborative efforts reflect her commitment to improving healthcare through scientific advancements.